Ischemia preconditioning is neuroprotective in a rat cerebral ischemic injury model through autophagy activation and apoptosis inhibition

Brazilian Journal of Medical and Biological Research

Volumn 46, Issue 7, 2013, Pages 580-588

  Xia, D Y ^a   Li, W ^b   Qian, H R ^a   Yao, S ^a   Liu, J G ^a   Qi, X K ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

Author keywords

Apoptosis; Autophagy; Focal cerebral ischemic reperfusion; Ischemic preconditioning

Indexed keywords

3 METHYLADENINE; BECLIN 1; CASPASE 3; LC3 I; LC3 II; MAMMALIAN TARGET OF RAPAMYCIN; PEPTIDES AND PROTEINS; RAPAMYCIN; TUBEROUS SCLEROSIS TYPE 1 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOPHAGY; BODY TEMPERATURE; CONTROLLED STUDY; DOPPLER FLOWMETRY; HYPOXIC ISCHEMIC ENCEPHALOPATHY; IMMUNOHISTOCHEMISTRY; ISCHEMIC PRECONDITIONING; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NICK END LABELING; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

RATTUS;

ADENINE; ANIMALS; APOPTOSIS; AUTOPHAGY; BRAIN ISCHEMIA; CASPASE 3; CEREBRUM; IMMUNOSUPPRESSIVE AGENTS; IN SITU NICK-END LABELING; ISCHEMIC PRECONDITIONING; MALE; NERVE DEGENERATION; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; SIROLIMUS; TIME FACTORS; TOR SERINE-THREONINE KINASES; TUMOR SUPPRESSOR PROTEINS;

EID: 84881562984     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/1414-431X20133161     Document Type: Article

References (29)

1. Hankey GJ, Jamrozik K, Broadhurst RJ, Forbes S, Burvill PW, Anderson CS, et al. Five-year survival after first-ever stroke and related prognostic factors in the Perth Community Stroke Study. Stroke 2000; 31: 2080-2086, doi: 10.1161/01.STR.31.9.2080.
2. Gosman-Hedstrom G, Claesson L, Klingenstierna U, Carlsson J, Olausson B, Frizell M, et al. Effects of acupuncture treatment on daily life activities and quality of life: a controlled, prospective, and randomized study of acute stroke patients. Stroke 1998; 29: 2100-2108, doi: 10.1161/01.STR.29.10.2100.
3. Naeser MA, Hamblin MR. Potential for transcranial laser or LED therapy to treat stroke, traumatic brain injury, and neurodegenerative disease. Photomed Laser Surg 2011; 29: 443-446, doi: 10.1089/pho.2011.9908.
4. Minnerup J, Schabitz WR. Improving outcome after stroke: time to treat new targets. Stroke 2012; 43: 295-296, doi: 10.1161/STROKEAHA.111.642363.
5. Meng R, Asmaro K, Meng L, Liu Y, Ma C, Xi C, et al. Upper limb ischemic preconditioning prevents recurrent stroke in intracranial arterial stenosis. Neurology 2012; 79: 1853-1861, doi: 10.1212/WNL.0b013e318271f76a.
6. Pignataro G, Scorziello A, Di RG, Annunziato L. Postischemic brain damage: effect of ischemic preconditioning and postconditioning and identification of potential candidates for stroke therapy. FEBS J 2009; 276: 46-57, doi: 10.1111/j.1742-4658.2008.06769.x.
7. Ratan RR, Siddiq A, Aminova L, Lange PS, Langley B, Ayoub I, et al. Translation of ischemic preconditioning to the patient: prolyl hydroxylase inhibition and hypoxia inducible factor-1 as novel targets for stroke therapy. Stroke 2004; 35: 2687-2689, doi: 10.1161/01.STR.0000143216.85349.9e.
8. Wegener S, Gottschalk B, Jovanovic V, Knab R, Fiebach JB, Schellinger PD, et al. Transient ischemic attacks before ischemic stroke: preconditioning the human brain? A multicenter magnetic resonance imaging study. Stroke 2004; 35: 616-621, doi: 10.1161/01.STR.0000115767.17923.6A.
9. Schaller B, Graf R. Cerebral ischemic preconditioning. An experimental phenomenon or a clinical important entity of stroke prevention? J Neurol 2002; 249: 1503-1511, doi: 10.1007/s00415-002-0933-8.
10. Janoff A, Weissmann G, Zweiofach BW, Thomas L. Pathogenesis of experimental shock. IV. Studies on lysosomes in normal and tolerant animals subjected to lethal trauma and endotoxemia. J Exp Med 1962; 116: 451-466,doi: 10.1084/jem.116.4.451.
11. Barone FC, White RF, Spera PA, Ellison J, Currie RW, Wang X, et al. Ischemic preconditioning and brain tolerance: temporal histological and functional outcomes, protein synthesis requirement, and interleukin-1 receptor antagonist and early gene expression. Stroke 1998; 29: 1937-1950, doi: 10.1161/01.STR.29.9.1937.
12. Zimmerman RF, Ezeanuna PU, Kane JC, Cleland CD, Kempananjappa TJ, Lucas FL, et al. Ischemic preconditioning at a remote site prevents acute kidney injury in patients following cardiac surgery. Kidney Int 2011; 80: 861-867, doi: 10.1038/ki.2011.156.
13. Quarrie R, Cramer BM, Lee DS, Steinbaugh GE, Erdahl W, Pfeiffer DR, et al. Ischemic preconditioning decreases mitochondrial proton leak and reactive oxygen species production in the postischemic heart. J Surg Res 2011; 165: 5-14, doi: 10.1016/j.jss.2010.09.018.
14. Levine B, Mizushima N, Virgin HW. Autophagy in immunity and inflammation. Nature 2011; 469: 323-335, doi: 10.1038/ nature09782.
15. Codogno P, Meijer AJ. Autophagy and signaling: their role in cell survival and cell death. Cell Death Differ 2005; 12 (Suppl 2): 1509-1518, doi: 10.1038/sj.cdd.4401751.
16. Wong E, Cuervo AM. Autophagy gone awry in neurodegenerative diseases. Nat Neurosci 2010; 13: 805-811, doi: 10.1038/nn.2575.
17. Samokhvalov V, Scott BA, Crowder CM. Autophagy protects against hypoxic injury in C. elegans. Autophagy 2008; 4: 1034-1041.
18. Carloni S, Buonocore G, Balduini W. Protective role of autophagy in neonatal hypoxia-ischemia induced brain injury. Neurobiol Dis 2008; 32: 329-339, doi: 10.1016/ j.nbd.2008.07.022.
19. Miyawaki T, Mashiko T, Ofengeim D, Flannery RJ, Noh KM, Fujisawa S, et al. Ischemic preconditioning blocks BAD translocation, Bcl-xL cleavage, and large channel activity in mitochondria of postischemic hippocampal neurons. Proc Natl Acad Sci U S A 2008; 105: 4892-4897, doi: 10.1073/ pnas.0800628105.
20. Kloner RA. Clinical application of remote ischemic preconditioning. Circulation 2009; 119: 776-778, doi: 10.1161/ CIRCULATIONAHA.108.832832.
21. Cheung MM, Kharbanda RK, Konstantinov IE, Shimizu M, Frndova H, Li J, et al. Randomized controlled trial of the effects of remote ischemic preconditioning on children undergoing cardiac surgery: first clinical application in humans. J Am Coll Cardiol 2006; 47: 2277-2282, doi: 10.1016/j.jacc.2006.01.066.
22. Dave KR, Saul I, Prado R, Busto R, Perez-Pinzon MA. Remote organ ischemic preconditioning protect brain from ischemic damage following asphyxial cardiac arrest. Neurosci Lett 2006; 404: 170-175, doi: 10.1016/j.neulet. 2006.05.037.
23. Johnston SC. Ischemic preconditioning from transient ischemic attacks? Data from the Northern California TIA Study. Stroke 2004; 35: 2680-2682, doi: 10.1161/ 01.STR.0000143322.20491.0f.
24. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74: 1124-1136, doi: 10.1161/ 01.CIR.74.5.1124.
25. Sheng R, Zhang LS, Han R, Liu XQ, Gao B, Qin ZH. Autophagy activation is associated with neuroprotection in a rat model of focal cerebral ischemic preconditioning. Autophagy 2010; 6: 482-494, doi: 10.4161/auto.6.4.11737.
26. Matsui Y, Takagi H, Qu X, Abdellatif M, Sakoda H, Asano T, et al. Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy. Circ Res 2007; 100: 914- 922, doi: 10.1161/01.RES.0000261924.76669.36.
27. Liu C, Gao Y, Barrett J, Hu B. Autophagy and protein aggregation after brain ischemia. J Neurochem 2010; 115: 68-78, doi: 10.1111/j.1471-4159.2010.06905.x.
28. Krajewski S, Krajewska M, Ellerby LM, Welsh K, Xie Z, Deveraux QL, et al. Release of caspase-9 from mitochondria during neuronal apoptosis and cerebral ischemia. Proc Natl Acad Sci U S A 1999; 96: 5752-5757, doi: 10.1073/ pnas.96.10.5752.
29. Cho BB, Toledo-Pereyra LH. Caspase-independent programmed cell death following ischemic stroke. J Invest Surg 2008; 21: 141-147, doi: 10.1080/08941930802029945.